Skip to content

NUtriGenomic Analysis in Twins

Genetic Determinants of Metabolic Responses to Isocaloric Carbohydrate and Fat Diet Strategies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01631123
Acronym
NUGAT
Enrollment
120
Registered
2012-06-28
Start date
2009-09-30
Completion date
2012-09-30
Last updated
2013-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Response to Dietary Modification

Keywords

Twins, High carbohydrat diet, High fat diet, Isocaloric, Nutrigenomics

Brief summary

This is an intervention study in healthy adult twins with the aim to investigate the genetic determination of metabolic responses towards an isocaloric high carbohydrate, low fat diet versus an isocaloric low carbohydrate, high fat diet.

Detailed description

The impact of carbohydrates, proteins and fatty acids as major components of daily nutrition on the development of metabolic illnesses is an objective of numerous clinical studies. However, the effect of an isocaloric diet on metabolism is less investigated and not well understood. This study aims to reveal genetic determinated metabolic responses to an isocaloric high carbohydrate, low fat diet versus an isocaloric low carbohydrate, high fat diet in healthy twins. This study generates information for further detailed nutrigenomic analysis. Twins receive an isocaloric diet rich in carbohydrates (55% carbohydrates, 15% protein, 30% fat) with dietary counselling for 5 weeks and afterwards with nutrients supplied for 6 days, followed by an isocaloric diet rich in saturated fat (40% carbohydrates, 15% protein, 45% fat) for 6 days with nutrients supplied and for 4 weeks with dietary counselling and again followed by another 6 days when nutrients were supplied. Anthropometry, blood tests and energy expenditure are performed after the period of diet rich in carbohydrates (Carb), after the first 6 days (HFshort) and at the end of the period of diet rich in fat (HFlong).

Interventions

OTHERIsocaloric high carbohydrate diet intervention

Time of 6 week, the last 6 days are standardized

OTHERIsocaloric high fat diet intervention

Time of 6 weeks; the first and the last 6 days are standardized

Sponsors

German Federal Ministry of Education and Research
CollaboratorOTHER_GOV
Charite University, Berlin, Germany
CollaboratorOTHER
Ernst von Bergmann Hospital
CollaboratorOTHER
University Hospital Tuebingen
CollaboratorOTHER
University of Southern California
CollaboratorOTHER
Ludwig-Maximilians - University of Munich
CollaboratorOTHER
Heidelberg University
CollaboratorOTHER
HealthTwist GmbH, Berlin, Germany
CollaboratorUNKNOWN
Max-Planck Institute of Molecular Cell Biology and Genetics
CollaboratorOTHER
Helmholtz Center Munich
CollaboratorUNKNOWN
German Institute of Human Nutrition
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy twins * BMI 18,5-35kg/m² * BMI difference \< 3kg/m² within the pair of twins * Stable weight during the last 3 months * Willingness to comply with the assigned diets over the study period

Exclusion criteria

* Consumptive diseases * Intake of metabolic influence a/o anticoagulent drugs (e.g. cortisone, ASS, antibiotics) * Diabetes type 1 and type 2 * Pregnancy * Chronic disease of heart, kidney, liver * High grade anaemia * High grade infection disease * Relevant change of body weight(+/- 2kg)during isoenergetic 12-weeks of dietary intervention * Missing data about primary outcome measures (IVGTT, MTT, data about dietary intake from food diaries or food protocols) * Significant deviation from dietary targets during the monitored 12 weeks isoenergetic period * Allergies including food allergies

Design outcomes

Primary

MeasureTime frameDescription
Genetic variance of change in insulin secretion and sensitivity after sequential diets6,7,12 weekschange in insulin secretion and sensitivity measured with an intravenous glucose tolerance test (IVGTT)

Secondary

MeasureTime frameDescription
Expression of inflammatory markers in blood and fat tissue6,7,12 weeksMeasurement of gene expression of inflammation cytokines and clock genes
Development of indices for the prediction of fat mass6,7,12 weeksChange of fat fraction in liver, abdominal and in the total body fat measuring by MRI/H1-spectroscopy, DEXA
Changes in vessel wall thickness of the carotid artery6,7,12 weeksVascular ultrasound
Measurement of activityin the 6th, 7th, 12th weekeach over 6 days measurement: activity protocol, pedometer and activity clock
Variance of insulin sensitivity after the sequential diets6, 7, 12 weekschange in insulin sensitivity measured with a meal tolerance test (MTT) allowing for the response of the intestinal hormones
Assessment of cognitive performance0,5,11 weeks
Nutritional and genetic influence on the circadian rhythm6, 7, 12 weeksmeasurement of hormones in saliva and urine and of circadian gene expression in monocytes and PBMCs
Epigenetic modification of DNA6,7,12 weeksChange in adipose tissue DNA methylation pattern
Biometric data6,7,12 weeksNutritional impact of the blood pressure, weight, body mass index, waist-hip ratio
Detection of the gastric emptying time6,7,12 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026